The aim of the present study was to estimate the accuracy of a novel non-invasive epicardial and endocardial electrophysiology system (NEEES) for mapping ectopic ventricular depolarizations.
Introduction
To understand the underlying mechanism and treatment of cardiac rhythm disorders, it is essential to correctly localize regional cardiac electrical activity and to delineate its activation and recovery sequence. The standard 12-lead surface EKG is commonly used, though it provides insufficient information about the accurate localization of the site of origin (SOO) of PVC or focal VT. In clinical practice, the SOO of cardiac arrhythmias and the sequence of cardiac excitation are commonly determined using invasive 3D electroanatomical mapping systems. However, these mapping systems may face significant limitations in addition to their invasive nature, in particular in patients presenting with non-sustained or haemodynamically intolerant arrhythmias. In recent years, great progress has been made to develop a method that provides extensive information on cardiac electrical activity on the basis of potentials observed from the body surface. Simultaneous acquisition of 3D anatomical and EKG data obtained by computed tomography (CT) or magnetic resonance imaging (MRI) and multi-channel bodysurface EGG recordings, the latter processed by mathematical algorithms in order to solve the inverse problem of electrocardiography, allows for non-invasive imaging of human cardiac electrical activity. Recently, non-invasive mapping of both epicardial and endocardial surfaces, 1,2 applying novel numerical algorithms, 3, 4 has been introduced into clinical practice.
The aim of the present study was to evaluate the feasibility of a novel non-invasive epicardial and endocardial electrophysiology system (NEEES, EP Solutions SA, Yverdon-les-Bains, Switzerland) for the diagnosis of focal ventricular arrhythmias.
Methods

Patient selection
A total of 20 symptomatic patients with ectopic ventricular arrhythmias were enrolled. Pre-procedural examination included a baseline 12-lead surface EKG, a 24-h Holter monitor, and transthoracic echocardiography. Nineteen patients presented with monomorphic PVCs (n ¼ 16) or VT (n ¼ 3). One patient presented with two different PVC morphologies. In one patient, a left ventricular diverticulum was present. The remaining patients had no underlying structural heart disease.
The study was approved by the institutional review board. Written informed consent was obtained from all patients.
Non-invasive epicardial and endocardial electrophysiology system
The methodology of non-invasive imaging using the NEEES has been previously described in detail. 2 Briefly, up to 28 custom-made vertical arrays incorporating 8 unipolar EKG electrodes each (for a maximum of 224 MRI or CT compatible electrodes) were placed onto the patient's torso, followed by same-day contrast MRI (Magnetom Avanto, 1.5 T, Siemens, Germany) or EKG-gated CT (Somatom Definition Flash 128, Siemens, Germany) scanning of the heart and thorax. Computed tomography or MRI data imported in the DICOM format were automatically processed by the NEEES to render a realistic 3D reconstruction of the torso geometry and surface electrodes' positions. The 3D heart model was plotted semi-automatically, and segmentation was performed using custom 3D editor software as part of the NEEES. Following heart and torso segmentation and volume reconstruction, the surfaces of the torso and cardiac chambers were triangulated and polygonal meshes were built.
Non-invasive mapping was completed at the patient's bedside before the invasive procedure. The electrode arrays were connected to the NEEES multi-channel EKG amplifier, and ≥4 PVC/VT beats were recorded using a bandwidth of 0.05-500 Hz, a sampling rate of 1000 samples/s, and an optional notch filter of 50 Hz. Electrocardiogram recording was performed during unrestricted breathing because some patients had only rare PVCs. Data from the body-surface EKG were processed by the NEEES using its inverse problem solution software in combination with anatomical data derived from MRI or CT of the heart and torso ( Figure 1) . A brief description of the numerical algorithms applied is provided as Supplementary material online, File S1.
The resulting epicardial and endocardial isopotential maps were reconstructed on the 3D volume and polygonal cardiac model and displayed as individual frames or activation movies. Isopotential maps of a minimum of four PVC/VT beats of identical morphology were analysed to determine the earliest zone of electrical activation. The centre of the zone of negative potentials spreading in a centrifugal fashion during early depolarization was considered the SOO. In some patients, electric potentials varied from 21 to 22 mV, a range comparable with the expected level of noise of the reconstructed electrograms. Conversely, a negative potential level exceeding 8 mV corresponded to a later stage of myocardial activation. Therefore, electric potentials from 23 to 28 mV were considered as the window of interest to localize the SOO. To enhance visualization of the activation sequence, isochronal and propagation maps were built using the maximum 2dU/dt approach.
Invasive 3D mapping and catheter ablation
The procedure was performed under conscious sedation using continuous infusion of 1% propofol. All patients underwent invasive mapping using a 3D electroanatomical mapping system (CARTO 3, Biosense Webster, Diamond Bar, CA, USA). Activation maps were reconstructed What's new? † A novel non-invasive epicardial and endocardial electrophysiology system accurately identified the site of PVC/VT origin † Use of the novel non-invasive epicardial and endocardial electrophysiology system before invasive mapping may aid in identifying the optimal ablation strategy during episodes of clinical PVC or stable VT. Catheter ablation was performed using an irrigated-tip catheter (ThermoCool Navistar, Biosense Webster) applying a power of 30 -50 W. If ablation was performed at the coronary cusps, energy delivery was limited to a maximum of 30 W. Acute procedural success was defined as freedom from recurrent clinical PVC/VT either occurring spontaneously or provoked by intravenous isoproterenol infusion during a 30-min waiting period that followed the last energy application.
A 12-lead surface EKG and 24-h Holter monitor the day before, the day after, and 6 months following the ablation procedure was completed in each patient. Late recurrence was defined as ≥1000 monomorphic PVCs on 24-h Holter monitoring or documentation of sustained monomorphic VT.
Detection of premature ventricular contraction/ventricular tachycardia origin comparing the non-invasive and invasive mapping systems
During the initial step, consecutive ectopic beats were analysed to reproducibly define the focal SOO. Foci were displayed on separate noninvasive isopotential maps, the latter of which were based on anatomical data derived from CT or MRI. In a second step, all non-invasively determined foci were marked on the same cardiac model and the distance between each was measured using the 'ruler' tool of the NEEES software.
Next, the NEEES data were compared with the results of the invasive procedure Preceding the invasive electrophysiology study, the NEEES data were analysed and the PVC/VT was categorized as RV or LV in origin and then subcategorized according to the RV/LV segment. During invasive mapping, the SOO was localized using the CARTO 3 system and compared with the SOO predicted by the NEEES. The SOO was considered identical if localized within the same heart segment. Final confirmation of the SOO was made by successful catheter ablation.
Results
A total of 21 different types of PVC/VT in 20 patients were targeted for ablation. Catheter ablation was successful in 19 of the 20 (95%) patients. At 6-month follow-up off AAD, 19 of the 20 (95%) patients were free from recurrent PVC/VT.
Reproducibility of premature ventricular contraction/ventricular tachycardia localization using the non-invasive epicardial and endocardial electrophysiology system
In all patients, the non-invasively predicted SOO for consecutive PVC/VT beats was localized within the same cardiac segment. The distance between any two foci during consecutive PVC/VT beats was ≤6 mm.
Premature ventricular contraction/ ventricular tachycardia site of origin
The PVC/VT SOO for all patients are summarized in Table 1 . In 12 of the 21 (57%) patients, the PVC/VT emanated from the RV; 6 of the 21 (29%) patients PVC/VT originated from the RVOT; and 6 of the 21 (29%) patients PVC/VT arose from other RV sites. One patient had two ectopic foci originating from the posterolateral wall of the RVOT and the mid-lateral RV wall. This latter case is illustrated in Figures 3-6 and in Supplementary material online, Videos S1 -S4. Left ventricular PVC/VT originated from the AMC in one, the mid-septal LV in one, the mid-posterior LV in one, the midanterior LV in one, the lateral MA in one, the septal MV in one, the posterior MV in one, and the lateral LV in one patient, respectively. In one patient, VT originated from a diverticulum located at the LV apex.
Correlation between non-invasive and invasive mapping
The NEEES correctly identified the chamber of interest in 20 of the 21 (95%) PVC/VTs and the respective ventricular segment in 18 of the 21 (86%) PVC/VTs. In 3 of the 21 (14%) PVC/VTs, the NEEES failed to provide the correct SOO. In the first case, the NEEES predicted the SOO at the RCC, but successful ablation was performed within the RVOT. In the second case, the predicted origin of PVC was from the lateral wall of the RVOT, while successful ablation was achieved targeting the anterior aspect of the RVOT. In the third case, the predicted PVC SOO was from the mid-lateral segment of the RV, but ablation was successful at the mid-posterior segment of the RV. In the latter case, acute procedural success was followed by PVC recurrence at 3-month follow-up.
In one patient, an LV diverticulum was found on cardiac MRI. The NEEES and CARTO 3 mapping system indicated that the VT originated from the diverticulum at the LV apex, but catheter ablation was unsuccessful. The patient underwent successful surgical cryoablation. Table 1 compares the results of the NEEES and invasive mapping and details the outcome of catheter ablation. Those cases incorrectly diagnosed by the NEEES are summarized in Figure 2 .
Discussion
A variety of non-invasive imaging systems to display electrical cardiac activity have been used as diagnostic tools in clinical cardiac electrophysiology. 5 -8 The method of non-invasive electrocardiographic imaging (ECGI) has demonstrated significant clinical relevance, allowing non-invasive reconstruction of local unipolar electrograms (EG) on the epicardial surface of the heart. 5 Advanced processing of reconstructed EG provides information on the cardiac activation sequence, the SOO of abnormal cardiac excitation and details about the arrhythmogenic substrate. 9 -11 The use of ECGI may facilitate rapid diagnosis of ventricular arrhythmias. Data from a randomized trial 12 demonstrated that the SOO of focal PVC could be detected in 95% of cases. Cakulev et al. 13 reported that in 8 of the 10 (80%) patients with PVCs, the ECGI correctly identified the ventricular SOO, as confirmed by successful ablation at these sites. Figure 4 Non-invasive reconstruction of epicardial and endocardial isopotential maps superimposed on the polygonal models of the ventricles at the beginning of the QRS complex of PVC #1. The earliest activation originates from the posterolateral wall of the RVOT.
NEEES mapping of premature ventricular contractions
Wang et al. 9 were able to predict the SOO of focal ventricular arrhythmias in 10 of the 11 (91%) RV and 11 of the 12 (92%) LV sites. Jamil-Copley et al.
14 reported an accuracy of 96% in predicting noninvasively the focal SOO of ventricular arrhythmias. However, none of the aforementioned studies utilized an ECGI capable of mapping both the endocardial and the epicardial surfaces of the heart. In a validation study, 2 the NEEES was able to identify with sufficient (,10 mm) accuracy the site of RV and LV pacing from various endocardial as well as epicardial sites.
In the present study, the NEEES was able to reproducibly localize the SOO over a series of consecutive recorded ectopic beats. The NEEES correctly diagnosed the respective ventricular segment in 86% of PVC/VT cases, thus establishing its value as an accurate diagnostic tool to identify the SOO of ventricular arrhythmias.
Knowledge of the location of the earliest site of activation before an invasive procedure, particularly in patients presenting with an ambiguous 12-lead surface EKG where the area of interest may be difficult to verify, should be of great value to the treating physician. The additional information provided by the NEEES may facilitate the planning of an appropriate invasive ablative strategy. Furthermore, from a single ectopic beat the complete activation sequence can be processed by the NEEES, facilitating successful mapping even in patients with haemodynamically intolerant or nonsustained arrhythmias. One major limitation of the standard 12-lead surface EKG is its low resolution in terms of localizing the SOO of ventricular ectopics. Multiple existing algorithms, often complex and difficult to apply, attempt to predict the earliest site of activation in ventricular arrhythmias, but many are hampered by their low specificity. 15, 16 Therefore, definitive diagnosis currently requires an invasive approach. The NEEES may overcome many of these limitations. Its use as a non-invasive diagnostic tool relies on the anatomical data derived from MRI or CT resulting in a highly accurate delineation of Figure 5 Non-invasive reconstruction of epicardial and endocardial isopotential maps superimposed on the polygonal models of the ventricles at the beginning of the QRS complex of PVC #2. The earliest activation originates from the mid-lateral wall of the RV.
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the true cardiac activation sequence. In addition, the NEEES can provide important information regarding the underlying mechanism of arrhythmia using a single ectopic beat, even if recording rare clinical PVCs would require pre-procedural monitoring at the patient's bedside over an extended period of time. Finally, the use of CT scanning, as part of the non-invasive electrocardiographic imaging procedure, will expose patients to radiation. The NEEES allows data processing from cardiac MRI to complete heart and torso reconstruction, which eliminates the need for radiation.
Limitations
The present study provides no comparison between the NEEES and alternative methods to localize the SOO of PVC/VT, such as diagnostic algorithms based on information from the 12-lead surface EKG or invasive pace mapping. Since patients included in the current study had no clinical indication for invasive epicardial mapping or ablation, epicardial breakthrough patterns could not be assessed.
In addition, no quantitative measures are given regarding the accuracy in localizing the ectopic foci. The current study compared ventricular segments to define successful catheter ablation, which as a reference has limited precision. The results of the present study underscore the need for further research on the accuracy of the NEEES. One area of improvement involves the complex anatomical region surrounding the left and right ventricular outflow tract. Differentiating PVC origin from the aortic sinus cusps and the RVOT is critical for the successful ablation outcome. On two occasions, the NEEES incorrectly identified the SOO in this complex region.
Conclusions
The novel non-invasive epicardial and endocardial electrophysiology mapping system accurately defines the site of focal PVC/VT origin and may facilitate planning of a successful ablation strategy. Combining anatomical data from MRI with information from the body-surface EKG eliminates the need for radiation exposure during the non-invasive diagnostic procedure.
